What is the Impact Factor of Molecular Therapy-Oncolytics?

The journal Molecular Therapy-Oncolytics is indexed in Web of Science (SCIE, quartile Q1) with official metrics continually updated on ImpaQ.

Is Molecular Therapy-Oncolytics indexed in Web of Science or Scopus?

Yes, Molecular Therapy-Oncolytics is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of N/A (Q1) and an H-index of 12.

Who publishes Molecular Therapy-Oncolytics and what is the Article Processing Charge (APC)?

Molecular Therapy-Oncolytics is published by Cell Press. For exact article processing charges and subscription guidelines, consult the official editorial guidelines.

What is the ISO-4 abbreviation and acronym of Molecular Therapy-Oncolytics?

The official ISO-4 abbreviation of Molecular Therapy-Oncolytics is "MOL THER-ONCOLYTICS". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Hybrid

Molecular Therapy-Oncolytics

Abbreviation (ISO):MOL THER-ONCOLYTICS

•

Identifier (ISSN):2372-7705(Print)

•

Publisher:Cell Press

Official Website Submission Portal Compare

Clarivate Impact Factor (IF 2024)

N/A

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

Impact Factor Trend (2018–2024)

Clarivate IF trend for Molecular Therapy-Oncolytics

WoS Q1

Annual Impact Factor Metric

Current (2024):5.3

Scopus SJR & Rank

N/A

SCImago Journal Rank citation prestige weighting

Scopus / Elsevier Data

H-Index (2021)

12 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation RateN/A

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

179articles/year

89.58% Gold OA•84.72% Original Research

Aims & Scope

Molecular Therapy — Oncolytics is an international, online-only, open access journal focusing on the development and clinical testing of viral, cellular, and other biological therapies targeting cancer.

Topics Covered (Recognized by AI)

Biology99.4%Genetics98.7%Medicine98.3%Internal medicine93.1%Cancer research91.7%Cancer86%Chemistry85.4%Biochemistry84.6%Immunology65.9%Gene58.6%Immune system56.4%Tumor cells39.1%Virology36.7%Virus35.1%Oncolytic virus33.5%Cell biology32.1%Pathology27.8%Cancer cell27.1%Apoptosis26.6%In vitro26.1%Cell culture25%Immunotherapy24.7%Cell21.5%

Primary Research Areas

Medicine Oncology

Official Website NLM PubMed Catalog Submission Portal

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

11 year

2024Latest

IF5.3

Articles / Year—

Total Citations—

2023

IF5.7

Articles / Year93

Total Citations1,137

2022

IF6.311

Articles / Year140

Total Citations3,605

2021

IF7.2

Articles / Year189

Total Citations5,966

2020

IF4.115

Articles / Year170

Total Citations5,599

Year	Impact Factor	Articles / Year	Total Citations
2024	5.3	—	—
2023	5.7	93	1,137
2022	6.311	140	3,605
2021	7.2	189	5,966
2020	4.115	170	5,599
2019	5.71	83	3,776
2018	3.69	41	2,047
2017	—	32	1,320
2016	—	44	3,464
2015	—	18	595
2014	—	10	229

SCImago & Scopus Journal Intelligence

Not indexed in SCImago / Scopus database

This journal is currently not indexed in Scopus or is an academic publication indexed exclusively in Web of Science (WoS).

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

3区MEDICINE, RESEARCH & EXPERIMENTAL

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Molecular Therapy-Oncolytics (abbr: MOL THER-ONCOLYTICS, ISSN: 2372-7705) is a peer-reviewed international scholarly journal in the field of Medicine, published by Cell Press in United States. The periodical holds tracked under Web of Science (SCIE) in quartile Q1, an H-index of 12.

The journal enforces rigorous peer evaluation with an annual output of approximately 179 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with APC fees are not specified. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.